In the Atherosclerosis Risk inCommunity Study of 8622 men and women, with a median follow-up of 11.9 years[20], β2M levels were associated with significantly increased risk of totalstroke in both those with and without chronic kidney disease. This evidence concerns the gene B2M and chronic kidney disease.